![]() |
市場調查報告書
商品編碼
2048032
聚乙二醇市場-全球產業規模、佔有率、趨勢、機會、預測:銷售管道、最終用途、地區和競爭格局分類,2021-2031年Polyethylene Glycol Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region & Competition, 2021-2031F |
||||||
全球聚乙二醇 (PEG) 市場預計將從 2025 年的 11.7 億美元成長到 2031 年的 15.2 億美元,複合年成長率達到 4.46%。
聚乙二醇(PEG)是一種用途廣泛的聚醚化合物,由環氧乙烷聚合而成,因其水溶性、生物相容性和無毒性而備受青睞。其市場促進因素包括其在製藥領域的關鍵作用,例如作為藥物製劑的重要添加劑以及作為粘合劑增強生物製藥的治療效果。此外,PEG還可用作水泥硬化劑和保水劑,從而促進建設產業的需求。在個人護理領域,其作為保濕劑和溶劑的特性也應用於化妝品。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 11.7億美元 |
| 市場規模:2031年 | 15.2億美元 |
| 複合年成長率:2026-2031年 | 4.46% |
| 成長最快的細分市場 | 個人護理 |
| 最大的市場 | 亞太地區 |
儘管市場具備這些穩健的基礎因素,但仍面臨許多挑戰。這些挑戰包括日益激烈的區域競爭和生產結構的轉變,這些都對歐美老牌製造商的利潤率構成了壓力。全球製造地的重組改變了供應鏈的依賴關係,使得傳統生產基地的製造商難以在成本方面有效競爭。歐洲化學工業理事會(CEFIC)的報告顯示,到2025年,中國將佔全球化工產品銷售額的46%。這項數據凸顯了生產能力的顯著轉移以及聚乙二醇等化學衍生物領域日益激烈的競爭格局。
市場擴張的主要驅動力是藥用輔料和先進藥物遞送系統需求的不斷成長。聚乙二醇正逐步應用於提高藥物活性成分的溶解度和生物利用度,而聚乙二醇化技術對於延長藥物半衰期至關重要,尤其是在複雜生物製藥和疫苗的研發中。大型生物製藥公司針對慢性疾病的積極研發活動進一步加劇了這種依賴性,從而持續推高了對高純度聚合物衍生物的需求。根據歐洲製藥製造商協會聯合會(EFPIA)於2025年6月發布的《2025年關鍵數據》報告,歐洲以研發為基礎的製藥業預計將在研發方面投入550億歐元,這是一筆與藥物製劑中功能性輔料需求成長直接相關的巨額投資。
同時,全球個人護理和化妝品行業的快速擴張正強勁推動市場成長。聚乙二醇(PEG)衍生物是護膚和護髮產品中不可或缺的成分,它們作為高效的保濕劑、乳化劑和溶劑,能夠改善產品的質地和穩定性。領先的美容集團正透過擴大生產規模來滿足消費者對高階功能性化妝品的需求,從而推動這一趨勢。歐萊雅集團於2025年2月發布的「2024會計年度業績」顯示,集團銷售額達到434.8億歐元,凸顯了強勁的商業性勢頭,支撐著對這些化學原料的需求。此外,更廣泛的工業領域對化學衍生物的持續依賴仍然十分重要。BASF於2025年10月發布的「2025年第三季業績」顯示,其銷售額達到143億歐元,顯示支持聚乙二醇價值鏈的化學品生產活動規模持續擴大。
日益激烈的區域競爭和不斷變化的生產環境是現有企業在全球聚乙二醇市場擴張的主要障礙。這項挑戰造成了競爭格局的失衡,使得傳統西方製造商在與新興經濟體低成本生產商競爭時難以維持盈利。由於聚乙二醇生產涉及高能耗的環氧乙烷轉化過程,公用事業和原料成本高的地區在結構上明顯處於劣勢。因此,西方生產商面臨利潤率下降的困境,被迫縮減產量或退出某些細分市場,從而阻礙了這些成熟市場的整體價值成長。
這種成本差異構成了嚴重的競爭壁壘,並限制了現有製造商主動設定產品價格的能力。例如,根據歐洲化學工業理事會(CEFIC)的預測,到2025年,歐洲天然氣價格將達到美國的3倍,這將為化學衍生物生產商帶來沉重的經濟負擔。這種投入成本的嚴重失衡直接限制了歐美聚乙二醇生產商的營運柔軟性,導致其在該地區市場佔有率下降,因為需求正日益集中於經濟效益更高的全球生產基地。
隨著製造商日益重視永續性和環境法規的合規性,生物基和可再生聚乙二醇衍生物的快速普及正在推動市場發生重大變革。這一趨勢意味著從石油化學衍生的乙烯轉向生質能衍生的生物乙烯原料,從而在不影響個人護理和工業應用效果的前提下,顯著降低聚合物的碳足跡。推動這一轉變的商業性因素體現在關鍵終端用戶產業對永續原料需求的強勁復甦。根據黑田國際於2025年2月發布的截至2024年12月31日的年度財務報告,消費照護領域的銷售量成長了7%,這主要得益於消費者對可再生材料解決方案日益成長的偏好。
同時,聚乙二醇化脂質奈米顆粒(LNP)在mRNA藥物遞送系統中的廣泛應用,正在創造一個清晰的高成長細分市場。與傳統的蛋白質結合方式不同,聚乙二醇化脂質在此應用中被用作關鍵的結構組分,以穩定奈米顆粒,從而促進mRNA療法的有效遞送,用於治療腫瘤和遺傳疾病等。這一專業成長領域正推動對高純度生物製程能力的大量投資,以確保這些複雜添加劑的穩定供應。根據默克集團(Merck KGaA)於2025年5月發布的「2025年第一季」報告,該公司生命科學業務部門的淨銷售額達到22億歐元。這項業績主要得益於製程解決方案部門需求的強勁復甦,該部門正是這些關鍵材料的供應商。
The Global Polyethylene Glycol (PEG) Market is forecast to expand from USD 1.17 Billion in 2025 to USD 1.52 Billion by 2031, achieving a 4.46% Compound Annual Growth Rate. PEG, a versatile polyether compound created from ethylene oxide polymerization, is highly valued for its water solubility, biocompatibility, and non-toxic attributes. The market's foundational drivers stem from PEG's crucial function in the pharmaceutical sector as a vital excipient in drug formulations and a conjugation agent for boosting the therapeutic efficacy of biologics. Furthermore, the construction industry contributes to demand by using PEG as a curing agent and moisture retention aid in cement, while the personal care sector utilizes its properties as a humectant and solvent in cosmetic products.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.17 Billion |
| Market Size 2031 | USD 1.52 Billion |
| CAGR 2026-2031 | 4.46% |
| Fastest Growing Segment | Personal Care |
| Largest Market | Asia Pacific |
Despite these robust underlying drivers, the market encounters a notable challenge: escalating regional competition and evolving production dynamics that exert pressure on profit margins for established western manufacturers. This consolidation of manufacturing influence globally has shifted supply chain dependencies, making it challenging for producers in traditional centers to compete effectively on cost. As reported by the European Chemical Industry Council, China captured 46% of global chemical sales in 2025, a statistic highlighting the significant relocation of manufacturing power and the intensified competitive landscape for chemical derivatives such as polyethylene glycol.
Market Driver
A primary catalyst for the market's expansion is the increasing demand for pharmaceutical excipients and advanced drug delivery systems. Polyethylene glycol is progressively employed to improve the solubility and bioavailability of active pharmaceutical ingredients, especially in developing complex biologics and vaccines, where PEGylation technology is vital for extending drug half-life. This reliance is intensified by major biopharmaceutical companies' aggressive research initiatives aimed at chronic diseases, generating a continuous need for high-purity polymer derivatives. As reported by the European Federation of Pharmaceutical Industries and Associations in their June 2025 'Key Data 2025' report, the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe, signifying a substantial capital infusion that directly correlates with greater consumption of functional excipients in drug formulations.
Simultaneously, the swift expansion of the global personal care and cosmetics industry robustly strengthens market growth. PEG derivatives are indispensable in skincare and hair care products, acting as efficient humectants, emulsifiers, and solvents that enhance product texture and stability. Major beauty conglomerates are propelling this trend by scaling production to satisfy consumer desire for premium and functional cosmetic items. L'Oreal's '2024 Annual Results' in February 2025 indicated group sales of 43.48 billion euros, highlighting the strong commercial momentum that underpins demand for these chemical ingredients. Additionally, the broader industrial sector's consistent reliance on chemical derivatives remains significant, with BASF's 'Q3 2025 Quarterly Statement' in October 2025 reporting sales of €14.3 billion, showcasing the sustained magnitude of chemical manufacturing activities supporting the polyethylene glycol value chain.
Market Challenge
Intensifying regional competition and evolving production dynamics pose a substantial barrier to the expansion of established participants within the Global Polyethylene Glycol Market. This challenge creates an unbalanced competitive environment, making it difficult for manufacturers in traditional western regions to sustain profitability when competing against lower-cost producers in emerging economies. Given that polyethylene glycol production involves energy-intensive processes to convert ethylene oxide, areas with higher utility and feedstock costs are at a distinct structural disadvantage. Consequently, western producers face diminished profit margins, compelling them to scale back production or withdraw from certain market segments, thereby hindering overall value growth in these mature markets.
This cost differential establishes a significant obstacle to competitiveness, constraining the capacity of established manufacturers to price their products assertively. For instance, in 2025, natural gas prices in Europe were three times higher than in the United States, according to the European Chemical Industry Council, imposing a considerable financial strain on producers of chemical derivatives. This profound imbalance in input costs directly curtails the operational flexibility of western polyethylene glycol manufacturers, leading to a reduction in their regional market share as demand increasingly gravitates toward more economically efficient global production hubs.
Market Trends
The market is undergoing significant transformation due to the rapid embrace of bio-based and renewable polyethylene glycol derivatives, as manufacturers increasingly focus on sustainability and compliance with environmental regulations. This trend entails a shift from ethylene derived from petrochemicals to bio-ethylene feedstocks obtained from biomass, which substantially lowers the polymer's carbon footprint without compromising its effectiveness in personal care and industrial uses. The commercial impetus behind this transition is evident in the strong rebound in demand for sustainable ingredients across vital end-use sectors. Croda International's 'Results for the year ended 31 December 2024' report in February 2025 indicated a 7% rise in sales volumes within its Consumer Care division, a recovery driven by increasing customer preference for renewable material solutions.
Concurrently, the expanding use of PEGylated lipid nanoparticles (LNPs) in mRNA drug delivery systems is establishing a distinct high-growth niche. In contrast to conventional protein conjugation, this application employs PEG-lipids as a crucial structural element to stabilize nanoparticles, facilitating the efficient delivery of mRNA therapeutics for conditions such as oncology and genetic disorders. This specialized growth area is spurring considerable investment in high-purity bioprocessing capabilities to guarantee a consistent supply of these intricate excipients. Merck KGaA's 'First Quarter 2025' report in May 2025 revealed that its Life Science business sector achieved net sales of €2.2 billion, a performance largely fueled by robust demand recovery for Process Solutions, which provides these essential materials.
Report Scope
In this report, the Global Polyethylene Glycol Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Polyethylene Glycol Market.
Global Polyethylene Glycol Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: